Menopausal Status and Disease Outcomes in Women With Rheumatoid Arthritis Receiving Anti-tumor Necrosis Factor (TNF) and Anti-IL-6 Therapies
Cureus · 09.06.2026
DOI: 10.7759/cureus.110543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 09.06.2026. Verfasst von Ghizlane Ghoullam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology, Ibn Sina Hospital Center, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology, Ibn Sina Hospital Center, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, MAR.
Zitieren
APA
Ghoullam, G., El Binoune, I., Amine, B., El Moubarik, I., Zemrani, S., Rostom, S., & Bahiri, R. (2026). Menopausal Status and Disease Outcomes in Women With Rheumatoid Arthritis Receiving Anti-tumor Necrosis Factor (TNF) and Anti-IL-6 Therapies. Cureus. https://doi.org/10.7759/cureus.110543
Vancouver
Ghoullam G, El Binoune I, Amine B, El Moubarik I, Zemrani S, Rostom S, et al. Menopausal Status and Disease Outcomes in Women With Rheumatoid Arthritis Receiving Anti-tumor Necrosis Factor (TNF) and Anti-IL-6 Therapies. Cureus. 2026. doi:10.7759/cureus.110543
BibTeX
@article{Ghoullam2026,
author = {Ghoullam, Ghizlane and El Binoune, Imane and Amine, Bouchra and El Moubarik, Ikram and Zemrani, Salma and Rostom, Samira and Bahiri, Rachid},
title = {Menopausal Status and Disease Outcomes in Women With Rheumatoid Arthritis Receiving Anti-tumor Necrosis Factor (TNF) and Anti-IL-6 Therapies},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.110543}
}
EUVIMED